Progyny earnings were $57.3M for the trailing 12 months ending Sep 30, 2024, with 10.7% growth year over year. The latest PGNY earnings report on Sep 30, 2024 announced Q3 2024 earnings of $10.4M, down 36.8% from last quarter. For the last reported fiscal year 2023 ending Dec 31, 2023, PGNY reported annual earnings of $62.0M, with 104.4% growth. The next PGNY earnings date is Feb 25, 2025.
PGNY past earnings growth
How has PGNY's earnings growth performed historically?
On PGNY's earnings call on Invalid Date, Progyny (NASDAQ: PGNY) reported Q3 2024 earnings per share (EPS) of $0.12, up 29.41% year over year. Total PGNY earnings for the quarter were $10.42 million. In the same quarter last year, Progyny's earnings per share (EPS) was $0.17.
The next PGNY earnings date is Invalid Date. Add PGNY to your watchlist to be reminded of Progyny's next earnings date.
What was PGNY's earnings growth in the past year?
As of Progyny's earnings date in Invalid Date, Progyny's earnings has grown 10.71% year over year. This is 11.31 percentage points lower than the US Health Information Services industry earnings growth rate of 22.03%. PGNY earnings in the past year totalled $57.27 million.
Is Progyny profitable or losing money?
As of the last Progyny earnings report, Progyny is currently profitable. Progyny's net profit (also called net income) for the twelve months ending Sep 30, 2024 was $57.27 million, a 10.2% increase year over year.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.